EYEGATE PHARMACEUTICALS INC Uncategorized Contracts & Agreements

26 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Licensed Agreement, dated as of November 5, 2023, between Bayon Therapeutics, Inc. and the Regents of the University of California
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2023
Form of Warrant Agency Agreement by and between the Registrant and VStock Transfer, LLC
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2023
Form of Class D Common Stock Purchase Warrant
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2023
Form of Class C Common Stock Purchase Warrant
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2023
Form of Underwriting Agreement between the Registrant and Ladenburg Thalmann & Co. Inc
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
DE
2023
Form of Inducement Letter
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2022
Offer Letter by and between Kiora Pharmaceuticals, Inc. and Melissa Tosca, dated as of August 18, 2022
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2022
Engagement Letter between EyeGate Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC, dated as of August 5, 2021
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2021
Amendment No. 2 to Sub-License Agreement, dated as of February 17, 2016, by and between Jade Therapeutics, Inc. and Biotime, Inc
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2020
Amendment No. 1 to Sub-License Agreement, dated as of September 18, 2015, by and between Jade Therapeutics, Inc. and Biotime, Inc
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2020
Exclusive Sub-License Agreement, dated as of September 12, 2013, by and between Jade Therapeutics, Inc. and Biotime, Inc
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
UT
2020
Description of Securities
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2020
Engagement Letter between EyeGate Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC, dated as of December 30, 2019
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2019
Engagement Letter, dated as March 15, 2018, by and between the Registrant and H.C. Wainwright & Co., LLC
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2018
Offer Letter between the Company and Sarah Romano, dated as of January 1, 2018
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2018
271 Waverly Oaks Road, Suite 108 Waltham, MA 02452
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2017
AT THE MARKET OFFERING AGREEMENT May 24, 2016
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2016
271 Waverly Oaks Road, Suite 108 Waltham, MA 02452
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2016
EYEGATE PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED EMPLOYMENTAGREEMENT
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
MA
2016
EYEGATEPHARMACEUTICALS, INC. Amendment to Amended and RestatedEmployment Agreement
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2015
UNDERWRITINGAGREEMENT between EYEGATEPHARMACEUTICALS, INC. and AEGISCAPITAL CORP., asRepresentative of the Several Underwriters
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2014
Form of Representative’s WarrantAgreement
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
NY
2014
EYEGATE PHARMACEUTICALS, INC. 271 Waverley Oaks Road Suite 108 Waltham, MA 02452
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
MA
2014
EYEGATE PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED EMPLOYMENTAGREEMENT
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
MA
2014
INDEMNIFICATIONAGREEMENT
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
DE
2014
Hereinafter known as the “OPTIS GROUP”
EYEGATE PHARMACEUTICALS INC
Pharmaceuticals
2014